nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Mesalazine—ulcerative colitis	0.498	1	CrCtD
Droxidopa—ADRB2—ulcerative colitis	0.151	1	CbGaD
Droxidopa—Mesalazine—Olsalazine—ulcerative colitis	0.079	0.252	CrCrCtD
Droxidopa—Aminosalicylic Acid—Mesalazine—ulcerative colitis	0.0675	0.215	CrCrCtD
Droxidopa—Carbidopa—Mesalazine—ulcerative colitis	0.0507	0.162	CrCrCtD
Droxidopa—Dopamine—Mesalazine—ulcerative colitis	0.0438	0.14	CrCrCtD
Droxidopa—Methyldopa—Mesalazine—ulcerative colitis	0.0438	0.14	CrCrCtD
Droxidopa—L-DOPA—Mesalazine—ulcerative colitis	0.0291	0.0928	CrCrCtD
Droxidopa—Blood pressure increased—Nicotine—ulcerative colitis	0.000515	0.0523	CcSEcCtD
Droxidopa—Aminosalicylic Acid—MPO—ulcerative colitis	0.000275	0.12	CrCbGaD
Droxidopa—Isoetarine—ADRB2—ulcerative colitis	0.000249	0.109	CrCbGaD
Droxidopa—Arrhythmia—Nicotine—ulcerative colitis	0.000231	0.0235	CcSEcCtD
Droxidopa—Mesalazine—MPO—ulcerative colitis	0.000216	0.0942	CrCbGaD
Droxidopa—Syncope—Nicotine—ulcerative colitis	0.000202	0.0205	CcSEcCtD
Droxidopa—Loss of consciousness—Nicotine—ulcerative colitis	0.000198	0.0201	CcSEcCtD
Droxidopa—Hypertension—Nicotine—ulcerative colitis	0.000194	0.0197	CcSEcCtD
Droxidopa—Urinary tract infection—Budesonide—ulcerative colitis	0.000193	0.0196	CcSEcCtD
Droxidopa—Mesalazine—PPARG—ulcerative colitis	0.000192	0.0837	CrCbGaD
Droxidopa—Confusional state—Nicotine—ulcerative colitis	0.000185	0.0188	CcSEcCtD
Droxidopa—Shock—Nicotine—ulcerative colitis	0.000181	0.0183	CcSEcCtD
Droxidopa—Aminosalicylic Acid—PTGS1—ulcerative colitis	0.00018	0.0787	CrCbGaD
Droxidopa—Cardiac failure congestive—Prednisolone—ulcerative colitis	0.000168	0.0171	CcSEcCtD
Droxidopa—Norepinephrine—SLC22A5—ulcerative colitis	0.000165	0.072	CrCbGaD
Droxidopa—Cardiac failure congestive—Hydrocortisone—ulcerative colitis	0.000164	0.0167	CcSEcCtD
Droxidopa—Urinary tract infection—Mesalazine—ulcerative colitis	0.000157	0.0159	CcSEcCtD
Droxidopa—Cardiac failure congestive—Triamcinolone—ulcerative colitis	0.000155	0.0157	CcSEcCtD
Droxidopa—Cardiac failure congestive—Methylprednisolone—ulcerative colitis	0.000154	0.0157	CcSEcCtD
Droxidopa—Dopamine—SLC22A5—ulcerative colitis	0.000153	0.0669	CrCbGaD
Droxidopa—Feeling abnormal—Nicotine—ulcerative colitis	0.000151	0.0154	CcSEcCtD
Droxidopa—Epinephrine—SLC22A5—ulcerative colitis	0.00015	0.0653	CrCbGaD
Droxidopa—Arrhythmia—Azathioprine—ulcerative colitis	0.000142	0.0144	CcSEcCtD
Droxidopa—Mesalazine—PTGS1—ulcerative colitis	0.000142	0.0618	CrCbGaD
Droxidopa—Cardiac failure congestive—Betamethasone—ulcerative colitis	0.00014	0.0142	CcSEcCtD
Droxidopa—Cardiac failure congestive—Dexamethasone—ulcerative colitis	0.00014	0.0142	CcSEcCtD
Droxidopa—Syncope—Budesonide—ulcerative colitis	0.000139	0.0141	CcSEcCtD
Droxidopa—Loss of consciousness—Budesonide—ulcerative colitis	0.000136	0.0138	CcSEcCtD
Droxidopa—Hypertension—Budesonide—ulcerative colitis	0.000134	0.0136	CcSEcCtD
Droxidopa—Confusional state—Budesonide—ulcerative colitis	0.000128	0.013	CcSEcCtD
Droxidopa—Shock—Budesonide—ulcerative colitis	0.000124	0.0126	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisone—ulcerative colitis	0.000122	0.0124	CcSEcCtD
Droxidopa—Dizziness—Nicotine—ulcerative colitis	0.000121	0.0123	CcSEcCtD
Droxidopa—Headache—Nicotine—ulcerative colitis	0.000115	0.0117	CcSEcCtD
Droxidopa—Syncope—Mesalazine—ulcerative colitis	0.000113	0.0115	CcSEcCtD
Droxidopa—Nausea—Mercaptopurine—ulcerative colitis	0.000113	0.0114	CcSEcCtD
Droxidopa—Loss of consciousness—Mesalazine—ulcerative colitis	0.000111	0.0112	CcSEcCtD
Droxidopa—Nausea—Nicotine—ulcerative colitis	0.000109	0.0111	CcSEcCtD
Droxidopa—Hypertension—Mesalazine—ulcerative colitis	0.000109	0.011	CcSEcCtD
Droxidopa—Feeling abnormal—Budesonide—ulcerative colitis	0.000104	0.0106	CcSEcCtD
Droxidopa—Confusional state—Mesalazine—ulcerative colitis	0.000104	0.0105	CcSEcCtD
Droxidopa—Isoprenaline—ADRB2—ulcerative colitis	0.000103	0.0452	CrCbGaD
Droxidopa—Aminosalicylic Acid—PTGS2—ulcerative colitis	0.000103	0.045	CrCbGaD
Droxidopa—Shock—Mesalazine—ulcerative colitis	0.000101	0.0103	CcSEcCtD
Droxidopa—Epinephrine—TNF—ulcerative colitis	9.81e-05	0.0428	CrCbGaD
Droxidopa—Norepinephrine—ADRB2—ulcerative colitis	9.58e-05	0.0418	CrCbGaD
Droxidopa—Arrhythmia—Prednisolone—ulcerative colitis	9.42e-05	0.00956	CcSEcCtD
Droxidopa—Feeling abnormal—Azathioprine—ulcerative colitis	9.31e-05	0.00945	CcSEcCtD
Droxidopa—Arrhythmia—Hydrocortisone—ulcerative colitis	9.2e-05	0.00934	CcSEcCtD
Droxidopa—Epinephrine—ADRB2—ulcerative colitis	8.69e-05	0.0379	CrCbGaD
Droxidopa—Arrhythmia—Triamcinolone—ulcerative colitis	8.66e-05	0.00879	CcSEcCtD
Droxidopa—Arrhythmia—Methylprednisolone—ulcerative colitis	8.64e-05	0.00877	CcSEcCtD
Droxidopa—Feeling abnormal—Mesalazine—ulcerative colitis	8.48e-05	0.00861	CcSEcCtD
Droxidopa—Dizziness—Budesonide—ulcerative colitis	8.37e-05	0.00849	CcSEcCtD
Droxidopa—Syncope—Prednisolone—ulcerative colitis	8.23e-05	0.00836	CcSEcCtD
Droxidopa—Mesalazine—PTGS2—ulcerative colitis	8.09e-05	0.0353	CrCbGaD
Droxidopa—Loss of consciousness—Prednisolone—ulcerative colitis	8.07e-05	0.00819	CcSEcCtD
Droxidopa—Syncope—Hydrocortisone—ulcerative colitis	8.04e-05	0.00816	CcSEcCtD
Droxidopa—Headache—Budesonide—ulcerative colitis	7.93e-05	0.00805	CcSEcCtD
Droxidopa—Hypertension—Prednisolone—ulcerative colitis	7.93e-05	0.00805	CcSEcCtD
Droxidopa—Loss of consciousness—Hydrocortisone—ulcerative colitis	7.88e-05	0.008	CcSEcCtD
Droxidopa—Arrhythmia—Dexamethasone—ulcerative colitis	7.86e-05	0.00798	CcSEcCtD
Droxidopa—Arrhythmia—Betamethasone—ulcerative colitis	7.86e-05	0.00798	CcSEcCtD
Droxidopa—Hypertension—Hydrocortisone—ulcerative colitis	7.74e-05	0.00786	CcSEcCtD
Droxidopa—Syncope—Triamcinolone—ulcerative colitis	7.57e-05	0.00769	CcSEcCtD
Droxidopa—Syncope—Methylprednisolone—ulcerative colitis	7.55e-05	0.00767	CcSEcCtD
Droxidopa—Nausea—Budesonide—ulcerative colitis	7.52e-05	0.00763	CcSEcCtD
Droxidopa—Dizziness—Azathioprine—ulcerative colitis	7.47e-05	0.00758	CcSEcCtD
Droxidopa—Loss of consciousness—Triamcinolone—ulcerative colitis	7.42e-05	0.00753	CcSEcCtD
Droxidopa—Loss of consciousness—Methylprednisolone—ulcerative colitis	7.4e-05	0.00752	CcSEcCtD
Droxidopa—Shock—Prednisolone—ulcerative colitis	7.37e-05	0.00748	CcSEcCtD
Droxidopa—Hypertension—Triamcinolone—ulcerative colitis	7.29e-05	0.0074	CcSEcCtD
Droxidopa—Hypertension—Methylprednisolone—ulcerative colitis	7.27e-05	0.00738	CcSEcCtD
Droxidopa—Shock—Hydrocortisone—ulcerative colitis	7.2e-05	0.00731	CcSEcCtD
Droxidopa—Headache—Azathioprine—ulcerative colitis	7.08e-05	0.00718	CcSEcCtD
Droxidopa—Confusional state—Methylprednisolone—ulcerative colitis	6.93e-05	0.00704	CcSEcCtD
Droxidopa—Syncope—Betamethasone—ulcerative colitis	6.87e-05	0.00697	CcSEcCtD
Droxidopa—Syncope—Dexamethasone—ulcerative colitis	6.87e-05	0.00697	CcSEcCtD
Droxidopa—Arrhythmia—Prednisone—ulcerative colitis	6.85e-05	0.00695	CcSEcCtD
Droxidopa—Dizziness—Mesalazine—ulcerative colitis	6.8e-05	0.00691	CcSEcCtD
Droxidopa—Shock—Triamcinolone—ulcerative colitis	6.78e-05	0.00688	CcSEcCtD
Droxidopa—Shock—Methylprednisolone—ulcerative colitis	6.76e-05	0.00687	CcSEcCtD
Droxidopa—Loss of consciousness—Betamethasone—ulcerative colitis	6.73e-05	0.00683	CcSEcCtD
Droxidopa—Loss of consciousness—Dexamethasone—ulcerative colitis	6.73e-05	0.00683	CcSEcCtD
Droxidopa—Nausea—Azathioprine—ulcerative colitis	6.71e-05	0.00681	CcSEcCtD
Droxidopa—Hypertension—Betamethasone—ulcerative colitis	6.61e-05	0.00671	CcSEcCtD
Droxidopa—Hypertension—Dexamethasone—ulcerative colitis	6.61e-05	0.00671	CcSEcCtD
Droxidopa—Headache—Mesalazine—ulcerative colitis	6.45e-05	0.00654	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisolone—ulcerative colitis	6.17e-05	0.00627	CcSEcCtD
Droxidopa—Shock—Dexamethasone—ulcerative colitis	6.15e-05	0.00624	CcSEcCtD
Droxidopa—Shock—Betamethasone—ulcerative colitis	6.15e-05	0.00624	CcSEcCtD
Droxidopa—Nausea—Mesalazine—ulcerative colitis	6.11e-05	0.0062	CcSEcCtD
Droxidopa—Feeling abnormal—Hydrocortisone—ulcerative colitis	6.03e-05	0.00612	CcSEcCtD
Droxidopa—Syncope—Prednisone—ulcerative colitis	5.98e-05	0.00607	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisone—ulcerative colitis	5.86e-05	0.00595	CcSEcCtD
Droxidopa—Hypertension—Prednisone—ulcerative colitis	5.76e-05	0.00585	CcSEcCtD
Droxidopa—Feeling abnormal—Triamcinolone—ulcerative colitis	5.68e-05	0.00576	CcSEcCtD
Droxidopa—Feeling abnormal—Methylprednisolone—ulcerative colitis	5.66e-05	0.00575	CcSEcCtD
Droxidopa—Shock—Prednisone—ulcerative colitis	5.36e-05	0.00544	CcSEcCtD
Droxidopa—Feeling abnormal—Betamethasone—ulcerative colitis	5.15e-05	0.00523	CcSEcCtD
Droxidopa—Feeling abnormal—Dexamethasone—ulcerative colitis	5.15e-05	0.00523	CcSEcCtD
Droxidopa—Dizziness—Prednisolone—ulcerative colitis	4.95e-05	0.00503	CcSEcCtD
Droxidopa—Dizziness—Hydrocortisone—ulcerative colitis	4.84e-05	0.00491	CcSEcCtD
Droxidopa—Headache—Prednisolone—ulcerative colitis	4.69e-05	0.00476	CcSEcCtD
Droxidopa—Headache—Hydrocortisone—ulcerative colitis	4.58e-05	0.00465	CcSEcCtD
Droxidopa—Dizziness—Triamcinolone—ulcerative colitis	4.56e-05	0.00462	CcSEcCtD
Droxidopa—Dizziness—Methylprednisolone—ulcerative colitis	4.55e-05	0.00461	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisone—ulcerative colitis	4.49e-05	0.00455	CcSEcCtD
Droxidopa—Nausea—Prednisolone—ulcerative colitis	4.45e-05	0.00452	CcSEcCtD
Droxidopa—Nausea—Hydrocortisone—ulcerative colitis	4.35e-05	0.00441	CcSEcCtD
Droxidopa—Headache—Triamcinolone—ulcerative colitis	4.32e-05	0.00438	CcSEcCtD
Droxidopa—Headache—Methylprednisolone—ulcerative colitis	4.31e-05	0.00437	CcSEcCtD
Droxidopa—Dizziness—Dexamethasone—ulcerative colitis	4.13e-05	0.0042	CcSEcCtD
Droxidopa—Dizziness—Betamethasone—ulcerative colitis	4.13e-05	0.0042	CcSEcCtD
Droxidopa—Nausea—Triamcinolone—ulcerative colitis	4.09e-05	0.00415	CcSEcCtD
Droxidopa—Nausea—Methylprednisolone—ulcerative colitis	4.08e-05	0.00415	CcSEcCtD
Droxidopa—Headache—Betamethasone—ulcerative colitis	3.92e-05	0.00398	CcSEcCtD
Droxidopa—Headache—Dexamethasone—ulcerative colitis	3.92e-05	0.00398	CcSEcCtD
Droxidopa—Nausea—Dexamethasone—ulcerative colitis	3.71e-05	0.00377	CcSEcCtD
Droxidopa—Nausea—Betamethasone—ulcerative colitis	3.71e-05	0.00377	CcSEcCtD
Droxidopa—Dizziness—Prednisone—ulcerative colitis	3.6e-05	0.00365	CcSEcCtD
Droxidopa—Headache—Prednisone—ulcerative colitis	3.41e-05	0.00346	CcSEcCtD
Droxidopa—Nausea—Prednisone—ulcerative colitis	3.23e-05	0.00328	CcSEcCtD
Droxidopa—ADRB1—Signaling Pathways—MAML2—ulcerative colitis	6.66e-06	0.000269	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MAML2—ulcerative colitis	6.6e-06	0.000266	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—ADCY5—ulcerative colitis	6.59e-06	0.000266	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	6.57e-06	0.000265	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MAML2—ulcerative colitis	6.52e-06	0.000263	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR6—ulcerative colitis	6.5e-06	0.000262	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CXCL8—ulcerative colitis	6.46e-06	0.00026	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	6.42e-06	0.000259	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	6.4e-06	0.000258	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	6.38e-06	0.000257	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—IL2—ulcerative colitis	6.32e-06	0.000255	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	6.3e-06	0.000254	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—ADCY5—ulcerative colitis	6.24e-06	0.000252	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GHRL—ulcerative colitis	6.22e-06	0.000251	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTGER4—ulcerative colitis	6.19e-06	0.00025	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL2—ulcerative colitis	6.17e-06	0.000249	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MAML2—ulcerative colitis	6.17e-06	0.000249	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	6.14e-06	0.000248	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTGER4—ulcerative colitis	6.13e-06	0.000247	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CALM3—ulcerative colitis	6.07e-06	0.000245	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	6.07e-06	0.000245	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTGER4—ulcerative colitis	6.05e-06	0.000244	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	6.05e-06	0.000244	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	6.04e-06	0.000244	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CALM3—ulcerative colitis	6.02e-06	0.000243	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	6.02e-06	0.000243	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	6e-06	0.000242	CbGpPWpGaD
Droxidopa—PAH—Disease—IL6—ulcerative colitis	5.98e-06	0.000241	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	5.97e-06	0.000241	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTGS2—ulcerative colitis	5.95e-06	0.00024	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RIPK2—ulcerative colitis	5.93e-06	0.000239	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	5.93e-06	0.000239	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—ALB—ulcerative colitis	5.92e-06	0.000239	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—IL2—ulcerative colitis	5.91e-06	0.000238	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTGER4—ulcerative colitis	5.73e-06	0.000231	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	5.69e-06	0.000229	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GHRL—ulcerative colitis	5.66e-06	0.000228	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	5.64e-06	0.000227	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	5.62e-06	0.000227	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	5.62e-06	0.000226	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GHRL—ulcerative colitis	5.61e-06	0.000226	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	5.58e-06	0.000225	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GHRL—ulcerative colitis	5.54e-06	0.000223	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—JAK2—ulcerative colitis	5.5e-06	0.000222	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CALM3—ulcerative colitis	5.49e-06	0.000221	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS1—ulcerative colitis	5.48e-06	0.000221	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	5.45e-06	0.00022	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CALM3—ulcerative colitis	5.44e-06	0.000219	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RIPK2—ulcerative colitis	5.4e-06	0.000218	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	5.39e-06	0.000217	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CALM3—ulcerative colitis	5.37e-06	0.000216	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RIPK2—ulcerative colitis	5.35e-06	0.000216	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RIPK2—ulcerative colitis	5.29e-06	0.000213	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	5.28e-06	0.000213	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GHRL—ulcerative colitis	5.24e-06	0.000211	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	5.16e-06	0.000208	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ADRB2—ulcerative colitis	5.15e-06	0.000208	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CALM3—ulcerative colitis	5.08e-06	0.000205	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—JAK2—ulcerative colitis	5.08e-06	0.000205	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	5.06e-06	0.000204	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	5.01e-06	0.000202	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	5.01e-06	0.000202	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RIPK2—ulcerative colitis	5e-06	0.000202	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	5e-06	0.000202	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TGFB1—ulcerative colitis	4.93e-06	0.000199	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CALM3—ulcerative colitis	4.93e-06	0.000199	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	4.92e-06	0.000199	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IL2—ulcerative colitis	4.8e-06	0.000194	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ABCB1—ulcerative colitis	4.72e-06	0.00019	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ADRB2—ulcerative colitis	4.69e-06	0.000189	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	4.65e-06	0.000188	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ADRB2—ulcerative colitis	4.65e-06	0.000187	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CXCL8—ulcerative colitis	4.63e-06	0.000187	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	4.62e-06	0.000187	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—JAK2—ulcerative colitis	4.61e-06	0.000186	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TGFB1—ulcerative colitis	4.61e-06	0.000186	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	4.58e-06	0.000185	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—JAK2—ulcerative colitis	4.58e-06	0.000185	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	4.52e-06	0.000182	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	4.44e-06	0.000179	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—IL2—ulcerative colitis	4.43e-06	0.000179	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ADCY5—ulcerative colitis	4.41e-06	0.000178	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	4.37e-06	0.000176	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ADCY5—ulcerative colitis	4.37e-06	0.000176	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ADRB2—ulcerative colitis	4.34e-06	0.000175	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—JAK2—ulcerative colitis	4.28e-06	0.000173	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	4.27e-06	0.000172	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	4.26e-06	0.000172	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	4.22e-06	0.00017	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	4.21e-06	0.00017	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CXCL8—ulcerative colitis	4.21e-06	0.00017	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	4.2e-06	0.000169	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CXCL8—ulcerative colitis	4.18e-06	0.000169	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—JAK2—ulcerative colitis	4.18e-06	0.000169	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—JAK2—ulcerative colitis	4.16e-06	0.000168	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	4.13e-06	0.000167	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	4.12e-06	0.000166	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	4.11e-06	0.000166	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	4.06e-06	0.000164	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TP53—ulcerative colitis	4.06e-06	0.000164	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—RELA—ulcerative colitis	4.05e-06	0.000163	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	4.03e-06	0.000163	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL2—ulcerative colitis	4.02e-06	0.000162	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—IL2—ulcerative colitis	4e-06	0.000161	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	3.98e-06	0.000161	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	3.95e-06	0.000159	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ADCY5—ulcerative colitis	3.94e-06	0.000159	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CXCL8—ulcerative colitis	3.91e-06	0.000158	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	3.89e-06	0.000157	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—JAK2—ulcerative colitis	3.89e-06	0.000157	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	3.84e-06	0.000155	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ABCB1—ulcerative colitis	3.84e-06	0.000155	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	3.83e-06	0.000155	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	3.83e-06	0.000154	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CXCL8—ulcerative colitis	3.81e-06	0.000154	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	3.8e-06	0.000153	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TP53—ulcerative colitis	3.79e-06	0.000153	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	3.79e-06	0.000153	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	3.75e-06	0.000151	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	3.74e-06	0.000151	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	3.74e-06	0.000151	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL2—ulcerative colitis	3.73e-06	0.000151	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ADCY5—ulcerative colitis	3.68e-06	0.000149	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	3.67e-06	0.000148	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	3.66e-06	0.000148	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL2—ulcerative colitis	3.65e-06	0.000147	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	3.63e-06	0.000146	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—ulcerative colitis	3.63e-06	0.000146	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	3.63e-06	0.000146	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	3.58e-06	0.000145	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ADCY5—ulcerative colitis	3.58e-06	0.000144	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCL8—ulcerative colitis	3.55e-06	0.000143	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	3.52e-06	0.000142	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	3.49e-06	0.000141	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	3.48e-06	0.00014	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—ulcerative colitis	3.45e-06	0.000139	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	3.42e-06	0.000138	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NFKB1—ulcerative colitis	3.41e-06	0.000138	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	3.4e-06	0.000137	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL2—ulcerative colitis	3.39e-06	0.000137	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	3.34e-06	0.000135	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PPARG—ulcerative colitis	3.29e-06	0.000133	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	3.26e-06	0.000132	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	3.22e-06	0.00013	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	3.17e-06	0.000128	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	3.16e-06	0.000127	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	3.1e-06	0.000125	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—ulcerative colitis	3.08e-06	0.000124	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—STAT3—ulcerative colitis	3.07e-06	0.000124	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	3.03e-06	0.000122	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	2.99e-06	0.000121	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	2.96e-06	0.00012	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ALB—ulcerative colitis	2.95e-06	0.000119	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	2.88e-06	0.000116	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—ulcerative colitis	2.84e-06	0.000115	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	2.75e-06	0.000111	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—JAK2—ulcerative colitis	2.72e-06	0.00011	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPARG—ulcerative colitis	2.67e-06	0.000108	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RELA—ulcerative colitis	2.64e-06	0.000106	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—ulcerative colitis	2.58e-06	0.000104	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL8—ulcerative colitis	2.49e-06	0.0001	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	2.48e-06	0.0001	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	2.46e-06	9.92e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	2.43e-06	9.79e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RELA—ulcerative colitis	2.4e-06	9.69e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—ulcerative colitis	2.4e-06	9.68e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	2.38e-06	9.6e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2—ulcerative colitis	2.38e-06	9.58e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—ulcerative colitis	2.36e-06	9.53e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RELA—ulcerative colitis	2.35e-06	9.48e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—ulcerative colitis	2.34e-06	9.44e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	2.3e-06	9.26e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	2.26e-06	9.13e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	2.26e-06	9.12e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—ulcerative colitis	2.25e-06	9.07e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	2.24e-06	9.05e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NFKB1—ulcerative colitis	2.22e-06	8.97e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	2.22e-06	8.97e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	2.22e-06	8.93e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	2.19e-06	8.83e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2—ulcerative colitis	2.16e-06	8.73e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	2.15e-06	8.69e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	2.14e-06	8.65e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—ulcerative colitis	2.14e-06	8.64e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	2.13e-06	8.61e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2—ulcerative colitis	2.12e-06	8.54e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	2.11e-06	8.5e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—ulcerative colitis	2.1e-06	8.47e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	2.1e-06	8.45e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	2.06e-06	8.32e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	2.05e-06	8.26e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	2.03e-06	8.19e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	2.03e-06	8.17e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	2.01e-06	8.1e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	2.01e-06	8.1e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	2e-06	8.08e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	2e-06	8.08e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—STAT3—ulcerative colitis	2e-06	8.06e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	1.99e-06	8.04e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	1.98e-06	8e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	1.97e-06	7.95e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	1.96e-06	7.91e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	1.94e-06	7.84e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	1.9e-06	7.65e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	1.88e-06	7.57e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	1.87e-06	7.53e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	1.87e-06	7.52e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—ulcerative colitis	1.85e-06	7.47e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	1.85e-06	7.45e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	1.83e-06	7.39e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	1.82e-06	7.35e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	1.81e-06	7.29e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	1.8e-06	7.28e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	1.78e-06	7.19e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	1.75e-06	7.06e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	1.74e-06	7.03e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	1.7e-06	6.87e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	1.69e-06	6.81e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	1.69e-06	6.8e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	1.67e-06	6.75e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	1.66e-06	6.69e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	1.66e-06	6.68e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	1.65e-06	6.66e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	1.64e-06	6.61e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	1.63e-06	6.56e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	1.62e-06	6.53e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	1.56e-06	6.3e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	1.54e-06	6.21e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	1.54e-06	6.2e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—ulcerative colitis	1.53e-06	6.15e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	1.52e-06	6.14e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	1.47e-06	5.94e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—ulcerative colitis	1.4e-06	5.63e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—ulcerative colitis	1.39e-06	5.61e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	1.38e-06	5.55e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	1.37e-06	5.52e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	1.37e-06	5.51e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—ulcerative colitis	1.36e-06	5.48e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	1.29e-06	5.19e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—ulcerative colitis	1.27e-06	5.13e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	1.27e-06	5.12e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	1.27e-06	5.11e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	1.26e-06	5.08e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—ulcerative colitis	1.24e-06	5.02e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	1.18e-06	4.75e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	1.16e-06	4.67e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	1.12e-06	4.54e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	1.04e-06	4.21e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	1.03e-06	4.15e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	9.56e-07	3.86e-05	CbGpPWpGaD
